The effect of anesthetic drugs and techniques on cerebral metabolism and blood flow with particular attention given to either toxic or protective effects continues to be the major thrust of this proposal. If protective effects are suspected, these will be tested in animal models of cerebral ischemia and cerebral hypoxia. Ongoing studies include those dealing with the possible protective effects of barbiturates and hypothermia. Animal models include those complete and incomplete global cerebral ischemia in the dog, incomplete focal cerebral ischemia in primates and cats (middle cerebral artery occlusion) and hypoxia in the mouse. Studies on the effect of anesthetics on CSF production and absorption are underway and are specifically directed at the anesthetic enflurane which has been suggested in previous reports to stimulate metabolic rate in the choroid plexus. The effect of the new anesthetic midazolam on cerebral metabolism and blood flow is also under examination as well as its potential for cerebral protection in the hypoxic mouse models. Because of the observed detrimental effects of prolonged hypothermia and re-warming we are planning studies to examine possible mechanisms of such a detrimental effect and a means by which these can be avoided. Because of the clinical use of prolonged barbiturate therapy, we are examining the effect of tolerance on cerebral metabolism during barbiturate therapy in animals for periods of 24 hours or greater.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS007507-19
Application #
3393588
Study Section
Neurology B Subcommittee 1 (NEUB)
Project Start
1978-09-01
Project End
1986-08-31
Budget Start
1985-09-01
Budget End
1986-08-31
Support Year
19
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Perkins, W J; Milde, L N; Milde, J H et al. (1991) Pretreatment with U74006F improves neurologic outcome following complete cerebral ischemia in dogs. Stroke 22:902-9
Milde, L N; Milde, J H; Gallagher, W J (1990) Effects of sufentanil on cerebral circulation and metabolism in dogs. Anesth Analg 70:138-46
Weglinski, M R; Lanier, W L (1990) The effects of transient hyperglycemia on brain glucose in rats anesthetized with halothane. Anesthesiology 73:291-6
Lanier, W L; Iaizzo, P A; Milde, J H (1990) The effects of intravenous succinylcholine on cerebral function and muscle afferent activity following complete ischemia in halothane-anesthetized dogs. Anesthesiology 73:485-90
Lanier, W L; Milde, J H; Sharbrough, F W (1990) Effects of suxamethonium on the cerebrum following disruption of the blood-brain barrier in dogs. Br J Anaesth 65:708-12
Michenfelder, J D; Milde, J H (1990) Postischemic canine cerebral blood flow appears to be determined by cerebral metabolic needs. J Cereb Blood Flow Metab 10:71-6
Lanier, W L; Perkins, W J; Karlsson, B R et al. (1990) The effects of dizocilpine maleate (MK-801), an antagonist of the N-methyl-D-aspartate receptor, on neurologic recovery and histopathology following complete cerebral ischemia in primates. J Cereb Blood Flow Metab 10:252-61
Black, S; Cucchiara, R F; Nishimura, R A et al. (1989) Parameters affecting occurrence of paradoxical air embolism. Anesthesiology 71:235-41
Mitrakou, A; Milde, J; Michenfelder, J et al. (1989) Rates of lactate appearance and disappearance and brain lactate balance after oral glucose in the dog. Horm Metab Res 21:236-9
Perkins, W J; Lanier, W L; Karlsson, B R et al. (1989) The effect of the excitatory amino acid receptor antagonist dizocilipine maleate (MK-801) on hemispheric cerebral blood flow and metabolism in dogs: modification by prior complete cerebral ischemia. Brain Res 498:34-44

Showing the most recent 10 out of 38 publications